Variant report

Variant	rs10981865
Chromosome Location	chr9:116421081-116421082
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr9:116410830..116412902-chr9:116418886..116421304,2	MCF-7	breast:
2	chr9:116420295..116422298-chr9:116424343..116426140,2	MCF-7	breast:
3	chr9:116419179..116421733-chr9:116422325..116423904,2	MCF-7	breast:
4	chr9:116170697..116173619-chr9:116417957..116421147,3	MCF-7	breast:
5	chr9:116173018..116174761-chr9:116419577..116421827,2	MCF-7	breast:
6	chr9:116420136..116422934-chr9:116424938..116428259,3	K562	blood:
7	chr9:116419739..116422322-chr9:116424476..116427451,2	K562	blood:

Variant related genes	Relation type
ENSG00000157653	Chromatin interaction
ENSG00000148229	Chromatin interaction

Extended variants
information (count: 33 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:26)

rs_ID	r²[population]
rs1077072	0.99[EUR][1000 genomes]
rs10817498	0.87[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs10981866	0.94[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs10981867	0.93[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs10981868	0.92[AFR][1000 genomes];1.00[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs10981869	0.88[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs10981870	0.88[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs10981871	0.94[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs10981872	0.88[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs10981873	0.88[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs10981874	0.88[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs10981875	0.93[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs16907724	0.91[AFR][1000 genomes];0.94[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs2101069	0.88[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs2622266	0.89[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs59286569	0.81[AMR][1000 genomes];0.99[EUR][1000 genomes];0.85[ASN][1000 genomes]
rs59638505	0.95[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs7031646	0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs7031648	0.87[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs7031666	0.87[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs7047639	0.87[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs7047776	0.83[AFR][1000 genomes];0.98[ASN][1000 genomes]
rs7048067	0.84[AFR][1000 genomes];0.82[ASN][1000 genomes]
rs745730	0.81[AMR][1000 genomes];0.99[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs7854061	0.86[AFR][1000 genomes];0.83[ASN][1000 genomes]
rs880205	0.89[EUR][1000 genomes];0.98[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:7 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv530949	chr9:115821128-116487796	Flanking Active TSS Enhancers Active TSS Weak transcription Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
2	nsv893748	chr9:116308709-116421786	Flanking Active TSS Enhancers Weak transcription Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
3	nsv430093	chr9:116330446-117325446	Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	165 gene(s)	inside rSNPs	diseases
4	nsv893749	chr9:116378759-116439749	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
5	nsv466512	chr9:116413751-116446881	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Genic enhancers	Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
6	nsv615220	chr9:116413751-116446881	Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
7	esv3326886	chr9:116417931-116422229	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	8 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:18 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:116416200-116422200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
2	chr9:116417800-116421200	Enhancers	HUVEC	blood vessel
3	chr9:116418800-116421200	Enhancers	Placenta	Placenta
4	chr9:116418800-116421800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr9:116419400-116421600	Enhancers	Primary hematopoietic stem cells short term culture	blood
6	chr9:116419400-116421800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
7	chr9:116419800-116421400	Enhancers	HSMM	muscle
8	chr9:116420000-116421200	Enhancers	ES-I3 Cell Line	embryonic stem cell
9	chr9:116420000-116421600	Enhancers	HepG2	liver
10	chr9:116420200-116425800	Weak transcription	Psoas Muscle	Psoas
11	chr9:116420400-116425800	Weak transcription	Left Ventricle	heart
12	chr9:116420600-116421200	Bivalent Enhancer	Fetal Stomach	stomach
13	chr9:116420800-116421200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr9:116420800-116421200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr9:116420800-116421800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
16	chr9:116420800-116427200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr9:116421000-116423800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr9:116421000-116425800	Weak transcription	Skeletal Muscle Female	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links